3 Active Ingredients Manufacturer, Vertically Integrated Garment Maker and Generic Formulations Company Stocks With a Strong Future Roadmap: Granules India, KPR Mill and Alembic Pharmaceuticals
- November 2, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Granules India, KPR Mill and Alembic Pharmaceuticals: ROE of 11.7% to 15.2% and FY22 to FY26 revenue CAGR of 8.4% to 9.2%. Prices as of 30 Oct 2026.
Quick Answer
The three cable, cement and housing developer stocks to watch are Granules India, KPR Mill and Alembic Pharmaceuticals. Their return on equity ranges from 11.7% to 15.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 9.2%. KPR Mill has the highest return on equity at 15.2%, while Granules India has the fastest revenue growth at 9.2% a year. Prices are based on the 30 October 2026 close, and this article is educational, not investment advice.
Cable, cement and housing developer stocks bring together companies with a visible plan for the years ahead. Granules India, KPR Mill and Alembic Pharmaceuticals cover an active ingredients manufacturer, a vertically integrated garment maker and a generic formulations company.
This list covers three cable, cement and housing developer stocks with complete current figures: Granules India, KPR Mill and Alembic Pharmaceuticals. Every figure comes from the latest reported financials and the 30 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Cable, Cement and Housing Developer Stocks?
Cable, cement and housing developer stocks are listed companies that make active ingredients, intermediates and finished doses, spin yarn, knit fabric and stitch garments for global brands, and sell generic formulations in the United States and other markets. Their earnings depend on export orders, approvals and input costs.
Cable, Cement and Housing Developer Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Granules India | 839.75 | 22,002 | 33.2 | 36.0 | 11.7 | 0.30 |
| KPR Mill | 1,114.6 | 34,974 | 38.3 | 33.8 | 15.2 | 0.10 |
| Alembic Pharmaceuticals | 797.85 | 14,914 | 21.6 | 35.7 | 11.9 | 0.25 |
On valuation, Granules India and Alembic Pharmaceuticals trade at a P/E below the industry P/E, while KPR Mill trades above it, which reflects the growth the market already expects. Readers comparing cable, cement and housing developer stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in cable, cement and housing developer stocks can use the coming numbers to test whether growth is holding.
Why Do Cable, Cement and Housing Developer Stocks Have a Strong Roadmap in India?
Cable, cement and housing developer stocks have a strong roadmap in India because steady generic demand, global brands adding Indian sourcing and wider approvals keep widening the market for these export focused makers.
- Generic demand. Regulated markets buy affordable medicines.
- Sourcing shift. Global brands add Indian factories.
- Approvals. New products widen the portfolio.
Why Granules India Features Among These Cable, Cement and Housing Developer Stocks
Among the cable, cement and housing developer stocks on this list, Granules India is a Hyderabad-based pharmaceutical manufacturer that makes active ingredients, intermediates and finished dosage forms, with a strong position in paracetamol, metformin and ibuprofen.
The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P/E of 33.2, below the industry P/E of 36.0.
Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore.
Roadmap: The company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.
What to watch: Monitor new product approvals and the share of finished dosages in total sales.
Why KPR Mill Features Among These Cable, Cement and Housing Developer Stocks
Among the export oriented shares on this list, KPR Mill is a Coimbatore-based, vertically integrated apparel maker that spins yarn, knits fabric and stitches garments for global brands. It also runs sugar and ethanol operations and a growing retail business.
Revenue rose from Rs 4,910 crore in FY22 to Rs 6,784 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 815 crore in FY25 to Rs 866 crore in FY26, a rise of 6.3%.
In the June 2026 quarter, revenue grew 9.3% year on year to Rs 1,970 crore, while net profit rose 21.6% to Rs 259 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 34,974 crore. The stock trades at a P/E of 38.3, above the industry P/E of 33.8.
Roadmap: The company is adding garment and fabric capacity and deepening ties with large international apparel buyers. Its control over each step from yarn to garment supports delivery speed and quality.
What to watch: Track garment export orders, capacity additions and the progress of the retail business.
Why Alembic Pharmaceuticals Features Among These Cable, Cement and Housing Developer Stocks
Among the three companies on this list, Alembic Pharmaceuticals is a Vadodara-based drug maker that sells generic formulations in the United States, branded medicines in India and active ingredients to other manufacturers.
In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%.
Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7.
Roadmap: The company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What to watch: Follow new approvals in the United States, the pace of complex generic launches and domestic growth.
Granules India vs KPR Mill vs Alembic Pharmaceuticals on Key Financials
The table below sets the three cable, cement and housing developer stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Granules India | 3,783 | 5,386 | 9.2% | 595 | 11.0% |
| KPR Mill | 4,910 | 6,784 | 8.4% | 866 | 12.8% |
| Alembic Pharmaceuticals | 5,356 | 7,399 | 8.4% | 671 | 9.1% |
KPR Mill posts the highest return on equity in this group at 15.2%. Alembic Pharmaceuticals has the largest FY26 revenue at Rs 7,399 crore, and Granules India shows the fastest revenue growth with a 9.2% compound annual rate. A useful habit with cable, cement and housing developer stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Granules India | 1,226 | 1,479 | 20.6% |
| KPR Mill | 1,802 | 1,970 | 9.3% |
| Alembic Pharmaceuticals | 1,717 | 2,165 | 26.1% |
Key Risks to Check Before Investing in Cable, Cement and Housing Developer Stocks
Every theme carries risks that deserve a check before any decision. For these cable, cement and housing developer stocks, the main points are: Long-term export oriented shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Currency moves. Export earnings move with the rupee.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter cable, cement and housing developer stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Cable, Cement and Housing Developer Stocks
Cable, cement and housing developer stocks suit investors who prefer to study business strength before price moves. Granules India, KPR Mill and Alembic Pharmaceuticals each have a clear plan to grow. Based on the 30 October 2026 close, Granules India trades at Rs 839.75, KPR Mill at Rs 1,114.6 and Alembic Pharmaceuticals at Rs 797.85. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these cable, cement and housing developer stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track cable, cement and housing developer stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are cable, cement and housing developer stocks?
Ans. Cable, cement and housing developer stocks are listed companies that make active ingredients, intermediates and finished doses, spin yarn, knit fabric and stitch garments for global brands, and sell generic formulations in the United States and other markets. Their earnings depend on export orders, approvals and input costs. This list looks at three of them, Granules India, KPR Mill and Alembic Pharmaceuticals, using reported FY22 to FY26 financials and the 30 October 2026 closing prices.
Which cable, cement and housing developer stocks are covered in this list?
Ans. This list covers Granules India, KPR Mill and Alembic Pharmaceuticals. Based on the 30 October 2026 close, Granules India traded at Rs 839.75, KPR Mill at Rs 1,114.6 and Alembic Pharmaceuticals at Rs 797.85. Their return on equity ranges from 11.7% to 15.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 9.2%.
Why do cable, cement and housing developer stocks have a strong future roadmap in India?
Ans. Cable, cement and housing developer stocks have a strong roadmap in India because steady generic demand, global brands adding Indian sourcing and wider approvals keep widening the market for these export focused makers. The main drivers are as follows. Generic demand. Regulated markets buy affordable medicines. Sourcing shift. Global brands add Indian factories. Approvals. New products widen the portfolio. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Granules India performed financially?
Ans. Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P/E of 33.2, below the industry P/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.
How has KPR Mill performed financially?
Ans. Revenue rose from Rs 4,910 crore in FY22 to Rs 6,784 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 815 crore in FY25 to Rs 866 crore in FY26, a rise of 6.3%. In the June 2026 quarter, revenue grew 9.3% year on year to Rs 1,970 crore, while net profit rose 21.6% to Rs 259 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 34,974 crore. The stock trades at a P/E of 38.3, above the industry P/E of 33.8. Looking ahead, the company is adding garment and fabric capacity and deepening ties with large international apparel buyers. Its control over each step from yarn to garment supports delivery speed and quality.
How has Alembic Pharmaceuticals performed financially?
Ans. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P/E of 21.6, below the industry P/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.
What risks should investors check before buying cable, cement and housing developer stocks?
Ans. Investors should check a few risks before buying cable, cement and housing developer stocks. Currency moves. Export earnings move with the rupee. Regulatory approvals. Plant inspections and approvals can affect supplies. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of cable, cement and housing developer stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 30 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
